# POLOXAMER 188

URL: https://app.greenveil.ai/ingredients/ingredient_unii_lqa7_b6_g8_jg
Categories: pharma
Identifier: chembl:CHEMBL2108134

> POLOXAMER 188. Route: INTRAMUSCULAR; Dosage form: INJECTION, POWDER, FOR SUSPENSION; Maximum daily exposure: 4 mg Assessed from 24 sources.

## Safety assessment

- Chemical concern: not yet assessed
- Rationale: Route: INTRAMUSCULAR; Dosage form: INJECTION, POWDER, FOR SUSPENSION; Maximum daily exposure: 4 mg

## Regulatory status

- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION, POWDER, FOR SUSPENSION; Maximum daily exposure: 4 mg
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: POWDER, FOR SUSPENSION; Potency: 0.2 %w/v
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION; Potency: 6 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: 2.2 mg
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SOLUTION; Potency: 0.1 %w/v
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 151 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 18 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CONCENTRATE; Maximum daily exposure: 3 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: GRANULE; Maximum daily exposure: 81 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: GRANULE, FOR SOLUTION; Maximum daily exposure: 624 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: POWDER, FOR SOLUTION; Maximum daily exposure: 500 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Maximum daily exposure: 30 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SOLUTION; Maximum daily exposure: 1800 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 1600 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION, EXTENDED RELEASE; Maximum daily exposure: 6 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 100 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, COATED; Potency: 3 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 6 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 37 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 3 mg
- US: inactive ingredient database — Route: PERIODONTAL; Dosage form: GEL; Potency: 55 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: CREAM; Potency: 1 %w/w
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as polymer.

_Assessed by Greenveil._